Company intelligence / Profile preview

PHARBIL Pharma

Bielefeld, Nordrhein-Westfalen, Germany

Ownership: Private
Development stage: Other

Overview

PHARBIL Pharma is a pharmaceutical contract development and manufacturing organization (CDMO/CMO) with expertise in the production, packaging, and quality control of conventional dosage forms, operating at the commercial supply stage. No proprietary drug pipeline or clinical results are reported for its own programs—it serves as a service provider to pharmaceutical and biotech industry partners.

Modalities: Small molecule
Industry: Contract Manufacturing Organization

Partnerships

GlaxoSmithKlineDr. Reddy's LaboratoriesApex LaboratoriesApicore Pharmaceuticals

Beyond the preview

Go deeper on PHARBIL Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on PHARBIL Pharma.

Explore the full profile